Syntekabio Inc.’s Post

The ultimate fate of any platform/tech-for-bio company: drug development. From 23andMe to Recursion to Atomwise and Schrodinger, making drugs seems to be the "state of lowest energy" (or highest value) in the business landscape of biopharma. But is this deep vertical integration really what's best for the industry? https://lnkd.in/eBQ-BfdZ #drugDiscovery #drugDevelopment #biotech #techForBio #techBio

With a focus on individual samples, singlicate analysis optimizes resource utilization, slashes consumable costs, and accelerates data generation—ideal for data-intensive drug discovery phases. Find out how singlicate analysis streamlines processes and maximizes results in GLP and non-GLP studies across various matrices and drug entities or biomarkers: https://lnkd.in/ddpDm2Jn #LifeSciences #DrugDevelopment #Bioanalysis

Interested to learn more about the state of #biotech in #Singapore? Read Diana Spencer's article in the latest issue of Drug Discovery World featuring insights from Yourgene Health 👉 https://lnkd.in/euhb6kdF #science #innovation #biomedicalscience #pharmaceutical #biotechnology #medtech #academia #lifescienceindustry #lifesciences #moleculardiagnostics #genomics #genomicmedicine #genomicresearch #asia #messengersinscience

As we power through Q3 2024, the pharmaceutical outsourcing sector is defined by AI innovation and groundbreaking drug developments. Proud to have my Molecule to Market podcast episode as a top performer, where I shared insights on commercialization and AI. 

SFBN Feed: What happens when an approved drug doesn’t work? https://lnkd.in/g2F5whPe Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. Today, we see the first approval of a drug to treat MASH, [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

Not only is the story of #CHO cells fascinating but their role in the production of life-saving active ingredients and in supporting #scientificresearch is absolutely amazing! Tens of the new drugs approved for human use every year and hundreds of the most innovative drugs on the market are produced thanks to CHO cells. 👉 But thinking that one CHO cell line is much like another is misleading... in fact different cell lines have different genetic characteristics of course but also different "behaviors“ and "tastes"... as we're talking about living organisms. 👉 at Magellan Biologics & Consulting we're working with CHO 4Tx®, a robust proprietary CHO cell line that was optimized for transient transfection. 👉 Since we know what our cells like, we have developed 3 media: one to cultivate them, one to transfect them - by simply adding DNA and one to feed and stimulate them once the transfection is effective, up to 14 days without additional feed. 👉 Since we know how they behave and what we can expect from them, in terms of viability and yield, we have developed a protocol which offers them a perfect work-life balance! 👉 Since we know we can trust them, you could trust them too! Want to know more about CHO 4Tx®? Please visit us on: https://lnkd.in/dBxfj8_D

I had the pleasure of meeting with Ingrid de Visser - Kamerling recently to discuss the progress of our ongoing Phase 2 study at the Centre for Human Drug Research (CHDR) and explore the evolving landscape of virus challenge studies in Europe. Looking forward to our continued collaboration and the promising paths ahead. #Biotech #ClinicalResearch #Innovation #Collaboration.

BIO International Convention San Diego, CA June 3-6, 2024 “America’s Finest City,” San Diego is known for its 70 miles of pristine beaches, the world-famous San Diego Zoo, and SeaWorld San Diego. It boasts the idyllic climate and location for this year’s Bio International Convention taking place this week, at the San Diego Convention Center. Meitheal is on hand and ready to connect with biotech leaders from across the globe. Meitheal continues to bring stabilization to Generics, expand into Biologics and Biosimilars and simplify access to life-changing medicine, for the common good. Think sustainability, think Meitheal. #Generics #Biologics #Biosimilars

#LexFridman Q: What is the most impressive thing AGI could do? #SamAltman A: When a system can significantly accelerate the rate of scientific discovery in the world. OpenAI #ChatGPT Just the beginning: ELaiN 🌟 AI-Chat for Scientists 🌟 is already accelerating scientific discovery. See here: https://lnkd.in/dAVfGqjm Watch Sam's interview here: https://lnkd.in/dyqkNtFP #AccelerateScience #DrugDiscovery #Genetics #DrugResearch #Biotechnology #ContractResearch #LIMS #ELN #LabData #LabManager #LabScientist #SLAS #NGS #Bioanalytics #Bioprocessing #Multimodal #BioPharma #Pharmaceutical #Bioinformatics

Are you developing new drugs for the hot target #GLP1R? Then listen up drug discovery experts! We are very excited to announce a significant breakthrough at Cube Biotech! Leveraging our 𝐍𝐚𝐭𝐢𝐯𝐞𝐌𝐏™ 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 to stabilize human GLP1R, we have successfully obtained novel small molecule binders by using an AS-MS screening approach with our collaboration partner Momentum Biotechnologies. Our highly thermal-stable, full-length, wild-type, human GLP1R available in our 𝐍𝐚𝐭𝐢𝐯𝐞𝐌𝐏™ 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 is easy to handle for #DrugDiscovery screenings with superior results in shorter lead times. Stay tuned for the upcoming launch on our web page. Get ready to explore hot membrane protein targets in our 𝐍𝐚𝐭𝐢𝐯𝐞𝐌𝐏™ 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 to revolutionize your research and drug discovery efforts! Is your target not in our Drug Discovery Pipeline? Interested in learning more about our 𝐍𝐚𝐭𝐢𝐯𝐞𝐌𝐏™ 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 for stabilization of any #MembraneProtein? 𝐓𝐡𝐞 𝐆𝐚𝐦𝐞 𝐢𝐬 𝐨𝐧: 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞 𝐮𝐬 𝐰𝐢𝐭𝐡 𝐲𝐨𝐮𝐫 𝐦𝐨𝐬𝐭 𝐜𝐨𝐦𝐩𝐥𝐞𝐱 𝐭𝐚𝐫𝐠𝐞𝐭𝐬! Book a meeting with me to discuss your project: https://lnkd.in/dNmvA45r #MembraneProteins #DrugDiscovery #AffinitySelectionMassSpectrometry #GLP1R #CubeBiotech